Skip to main content

Table 1 MEL58 ELIspot data comparisons across time (weeks 0–12)

From: A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients

  1. Bolded numbers represent P-values of less than 0.1
Back to article page